Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IMMU - More Explanations Due From Gilead

IMMU - More Explanations Due From Gilead

Immunomedics Inc.
  • GILD reports earnings after-hours.
  • Remdesivir could revive growth in the short term. However, revenue from HIV and HCV could be dead for now.
  • GLPG's R&D pipeline has suffered some setbacks and may not be the boon GILD once thought.
  • The IMMU deal could limit GILD's ability to go elephant hunting in the future.
  • GILD needs more explanations this quarter. I rate the stock a hold.

For further details see:

More Explanations Due From Gilead
Stock Information
Company Name: Immunomedics Inc.
Stock Symbol: IMMU
Market: NASDAQ
Website: immunomedics.com
Menu
IMMU IMMU Quote IMMU Short IMMU News IMMU Articles IMMU Message Board
Get IMMU Alerts

News, Short Squeeze, Breakout and More Instantly...